Hovid likely to offset capacity loss


Mitigating factor: Workers packing and labelling bottles containing pharmaceutical products at Hovid’s plant in Chemor which contributes 70 of company’s total capacity.

CIMB Research: Chemor plant resumption good news

PETALING JAYA: Although Hovid Bhd’s Ipoh plant is still suspended from operations, the resumption of production at its Chemor plant bodes well for the Perak-based healthcare and pharmaceutical company, which had the manufacturing licences of both the plants revoked in January.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Hovid

   

Next In Business News

Powering on data centres
Medical insurance premiums on the rise
Kelington to reap the benefits of a diversified business strategy
Rising data centre ability
Making scents of success
Investors brace for 5% Treasury yields
Are there too many GPs and is the healthcare system overwhelmed?
Sapura Energy takes a step to turn the tide
Japan frets over relentless yen slide as BoJ keeps ultra-low rates
Singapore’s growth trajectory remains intact

Others Also Read